Acute Complications After High-Dose Chemotherapy and Stem-Cell Rescue in Pediatric Patients With High-Risk Neuroblastoma Treated in Countries With Different Resources

PURPOSE: High-dose chemotherapy with autologous stem-cell rescue (SCR) is a key component of high-risk neuroblastoma (HRNB) therapy. Carboplatin, etoposide, and melphalan (CEM) or busulfan and melphalan (Bu/Mel) are the most evaluated, effective high-dose chemotherapy for HRNB on the basis of result...

Descripción completa

Detalles Bibliográficos
Autores principales: Elzembely, Mahmoud M., Park, Julie R., Riad, Khaled F., Sayed, Heba A., Pinto, Navin, Carpenter, Paul A., Baker, K. Scott, El-Haddad, Alaa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Clinical Oncology 2018
Materias:
Original Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6223425/
https://www.ncbi.nlm.nih.gov/pubmed/30241255
http://dx.doi.org/10.1200/JGO.17.00118

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6223425/
https://www.ncbi.nlm.nih.gov/pubmed/30241255
http://dx.doi.org/10.1200/JGO.17.00118

Ejemplares similares